Henry Nasrallah

Dr. Sasidhar Gunturu is a distinguished psychiatrist, educator, and healthcare leader currently serving as Vice Chair for Education, Research, and Faculty Development and Director of the Psychiatry Residency Training Program at BronxCare Health System, a role he has held since June 2021.<br><br>

Dr. Gunturu completed his medical education at NTR University of Health Sciences in India before pursuing psychiatric training in the United States. He completed his General Psychiatry Residency at the Icahn School of Medicine at Mount Sinai (Bronx Lebanon Hospital), followed by a Consultation-Liaison Psychiatry Fellowship at the University of Miami Miller School of Medicine and a Public Psychiatry Fellowship at Columbia University. He is a board-certified Diplomate of the American Board of Psychiatry and Neurology and holds academic appointments as Clinical Assistant Professor of Psychiatry at Icahn School of Medicine at Mount Sinai, Clinical Associate Professor and Clerkship Site Director at St. George's University Medical School, and Adjunct Professor of Clinical Medicine and Clerkship Site Director at the American University of Antigua Medical School. <br><br>

Beyond academia, Dr. Gunturu serves as Medical Director for Psychiatric Integrated Services & Community Psychiatry at BronxCare and Consulting Chief Behavioral Health Officer at Essen Health Care, overseeing behavioral health delivery for underserved South Bronx populations. <br><br>

Nationally, Dr. Gunturu serves as President-Elect of the APA's Bronx District Branch and is a Distinguished Fellow of the American Psychiatric Association. His committee work includes the APA Council on Healthcare Systems and Financing, the APA Psychiatric Services Award Selection Committee, the Academy of Consultation-Liaison Psychiatry's Guidelines and Evidence-Based Medicine and Research Subcommittees, and the Curriculum Committee of the American Academy of Directors in Psychiatry Residency Training. Institutionally, he chairs BronxCare's Wellness Committee and serves on its Medical Executive Committee, Credentialing Committee, IRB, Ethics Committee, and GME Committee. <br><br>

An accomplished scholar, Dr. Gunturu has authored more than 50 peer-reviewed publications, delivered over 90 conference presentations, and holds editorial and peer-review roles with leading psychiatric journals. His honors include the Outstanding Resident of the Year Award from the American Psychiatric Association and the BronxCare Teacher of the Year Award. He previously served as Chief Resident in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, an early marker of his leadership trajectory.<br><br>

Widely regarded as a mentor to emerging psychiatrists, Dr. Gunturu remains focused on research innovation, faculty development, and expanding equitable mental health access. His breadth spanning residency education, community psychiatry, and national leadership makes him an authoritative voice on the future of psychiatric training. Outside of medicine, he enjoys traveling, Scuba diving, jet skiing, and spending time with his dog.

Dr. Henry Nasrallah, a widely recognized researcher and educator, is Professor and Vice Chair for Faculty Mentorship at the University of Cincinnati. He did his psychiatric residency at the University of Rochester and his neuroscience fellowship at NIH. He served as chair of psychiatry for 12 years at The Ohio State University and as chair of both psychiatry and neurology for 6 years at Saint Louis University. He also served for 4 years as Associate Dean at the University of Cincinnati.

He is internationally recognized for his research in schizophrenia and related psychoses. He has published 14 books and 670 articles and served as Editor of 3 psychiatric journals. He is a distinguished life fellow of the APA and a member of numerous scientific organizations. He has received 95 federal, state, and industry grants. He has received numerous awards for both teaching and research including Golden Apple Teaching awards from 4 universities, the U.S. Educator of the Year from The Psychiatric Times, the Stanley Dean Award for schizophrenia from the American College of Psychiatrists, and the highest research award at The Ohio State University and the highest research award (The Drake Medal) at UC College of Medicine.

He is a mover and shaker in the field of psychiatry, having founded 4 psychiatric journals and established the only global schizophrenia society (SIRS) with 1800 members attending its annual congress. He has served as president of 6 professional organizations and was recognized by Reuter Media as one of the world’s most influential minds, ranking in the top 1% in the world in terms of his publications being cited. He also established a charitable foundation (curesz.org) with his former patient Bethany Yeiser, to advocate and support patients with serious neuropsychiatric disorders, and their families.

Jose M. Rubio, MD, PhD, is Assistant Professor of Psychiatry at the Feinstein Institutes for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a board-certified psychiatrist and physician-investigator. Dr. Rubio obtained his MD and PhD from the Universitat de Valencia and Universidad Complutense de Madrid (Spain) respectively, and psychiatry residency at the Zucker Hillside Hospital – Hofstra University (New York). His work focuses on relapse prevention, treatment resistance, and antipsychotic effects in schizophrenia. He has received funding from industry and the National Institutes of Health (NIH) to lead multiple research projects, and has received recognition by multiple organizations including the Alpha Omega Alpha Honor Society, the American Society of Clinical Psychopharmacology (ASCP) or the Schizophrenia International Research Society (SIRS). He is an associate member of the American College of Neuropsychopharmacology (ACNP).

After completing residency in 2017, he obtained a Career Development Award by the National Institutes of Health to study biomarker development and relapse in schizophrenia.

As an early career investigator, Dr Rubio has published over 50 articles, focusing on the application of evidence-based interventions in the real world, neuroimaging biomarkers, and prevention of relapse in schizophrenia. Some of the phenomena that he studies is the underutilization of long acting injectable antipsychotics and clozapine, and the neurobiological mechanisms leading to relapse or decrement in antipsychotic efficacy over time.

Dr Rubio regularly lectures on the treatment of schizophrenia in a variety of academic and industry settings. In addition, he supervises residents in a specialized psychosis clinic and co-leads the research track at the Zucker Hillside Hospital psychiatry residency program. Dr. Rubio has received various awards, including the early career investigator travel award for the Schizophrenia International Research Society (SIRS) and the American College of Neuropsychopharmacology (ACNP) and the Alkermes Pathways Award for Junior Investigators.